NCT06778746 Use of Biologics for Severe Asthma in Hong Kong
| NCT ID | NCT06778746 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 360 participants |
| Start Date | 2024-12-26 |
| Primary Completion | 2026-12-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 360 participants in total. It began in 2024-12-26 with a primary completion date of 2026-12-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older. * Patients diagnosed with severe asthma per the Global Initiative for Asthma (GINA) guidelines. * Patients who have received biologic therapy for treatment of asthma (including those who received just one dose to allow assessment of the reason for withdrawal) Exclusion Criteria: \- Patients with respiratory diseases with other known significant respiratory diseases, including tuberculosis (TB)-destroyed lung parenchyma, history of lung resection and lung cancer
Contact & Investigator
Fanny WS Ko, MD
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT06778746 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06778746 currently recruiting?
Yes, NCT06778746 is actively recruiting participants. Contact the research team at fannyko@cuhk.edu.hk for enrollment information.
Where is the NCT06778746 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06778746 clinical trial?
NCT06778746 is sponsored by Chinese University of Hong Kong. The principal investigator is Fanny WS Ko, MD at Chinese University of Hong Kong. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.